Cargando…

Prognostic significance of metallothionein expression in renal cell carcinoma

BACKGROUND: Metallothionein (MT) protein expression deficiency has been implicated in carcinogenesis while MT over expression in tumors is indicative of tumor resistance to anti-cancer treatment. The purpose of the study was to examine the expression of MT expression in human renal cell carcinoma (R...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitropoulos, Dionisios, Kyroudi-Voulgari, Aspasia, Theocharis, Stamatis, Serafetinides, Efraim, Moraitis, Epaminondas, Zervas, Anastasios, Kittas, Christos
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC545945/
https://www.ncbi.nlm.nih.gov/pubmed/15655072
http://dx.doi.org/10.1186/1477-7819-3-5
_version_ 1782122221650575360
author Mitropoulos, Dionisios
Kyroudi-Voulgari, Aspasia
Theocharis, Stamatis
Serafetinides, Efraim
Moraitis, Epaminondas
Zervas, Anastasios
Kittas, Christos
author_facet Mitropoulos, Dionisios
Kyroudi-Voulgari, Aspasia
Theocharis, Stamatis
Serafetinides, Efraim
Moraitis, Epaminondas
Zervas, Anastasios
Kittas, Christos
author_sort Mitropoulos, Dionisios
collection PubMed
description BACKGROUND: Metallothionein (MT) protein expression deficiency has been implicated in carcinogenesis while MT over expression in tumors is indicative of tumor resistance to anti-cancer treatment. The purpose of the study was to examine the expression of MT expression in human renal cell carcinoma (RCC) and to correlate MT positivity, the pattern and extent of MT expression with tumor histologic cell type and nuclear grade, pathologic stage and patients' survival. PATIENTS AND METHODS: The immunohistochemical expression of MT was determined in 43 formalin-fixed and paraffin-embedded RCC specimens, using a mouse monoclonal antibody that reacts with both human MT-I and MT-II. Correlation was sought between immunohistochemical (MT positivity, intensity and extension of staining) and clinico-pathological data (histological cell type, tumor nuclear grade, pathologic stage and patients' survival). RESULTS: Positive MT staining was present in 21 cases (49%), being mild/moderate and intense in 8 and 13 cases, respectively. The pattern was cytoplasmic in 7 cases and was both cytoplasmic and nuclear in 14 cases. MT expression in a percentage of up to 25% of tumor cells (negative MT staining included) was observed in 31 cases, in a percentage 25–50% of tumor cells in 7 cases, and in a percentage of 50–75% of tumor cells in 5 cases. There was no significant correlation of MT intensity of staining to histological type, stage and patients' survival, while it was inversely correlated to higher tumor nuclear grade. MT extent of staining did not correlate with histological type, nuclear grade, and pathologic stage while a statistically significant association was found with patients' survival. CONCLUSIONS: The inverse correlation between MT staining intensity and tumor nuclear grade in RCC suggests a role of MT in tumor differentiation process. Since extent of MT expression is inversely correlated with survival it may be possibly used as a clinical prognostic parameter.
format Text
id pubmed-545945
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-5459452005-01-28 Prognostic significance of metallothionein expression in renal cell carcinoma Mitropoulos, Dionisios Kyroudi-Voulgari, Aspasia Theocharis, Stamatis Serafetinides, Efraim Moraitis, Epaminondas Zervas, Anastasios Kittas, Christos World J Surg Oncol Research BACKGROUND: Metallothionein (MT) protein expression deficiency has been implicated in carcinogenesis while MT over expression in tumors is indicative of tumor resistance to anti-cancer treatment. The purpose of the study was to examine the expression of MT expression in human renal cell carcinoma (RCC) and to correlate MT positivity, the pattern and extent of MT expression with tumor histologic cell type and nuclear grade, pathologic stage and patients' survival. PATIENTS AND METHODS: The immunohistochemical expression of MT was determined in 43 formalin-fixed and paraffin-embedded RCC specimens, using a mouse monoclonal antibody that reacts with both human MT-I and MT-II. Correlation was sought between immunohistochemical (MT positivity, intensity and extension of staining) and clinico-pathological data (histological cell type, tumor nuclear grade, pathologic stage and patients' survival). RESULTS: Positive MT staining was present in 21 cases (49%), being mild/moderate and intense in 8 and 13 cases, respectively. The pattern was cytoplasmic in 7 cases and was both cytoplasmic and nuclear in 14 cases. MT expression in a percentage of up to 25% of tumor cells (negative MT staining included) was observed in 31 cases, in a percentage 25–50% of tumor cells in 7 cases, and in a percentage of 50–75% of tumor cells in 5 cases. There was no significant correlation of MT intensity of staining to histological type, stage and patients' survival, while it was inversely correlated to higher tumor nuclear grade. MT extent of staining did not correlate with histological type, nuclear grade, and pathologic stage while a statistically significant association was found with patients' survival. CONCLUSIONS: The inverse correlation between MT staining intensity and tumor nuclear grade in RCC suggests a role of MT in tumor differentiation process. Since extent of MT expression is inversely correlated with survival it may be possibly used as a clinical prognostic parameter. BioMed Central 2005-01-17 /pmc/articles/PMC545945/ /pubmed/15655072 http://dx.doi.org/10.1186/1477-7819-3-5 Text en Copyright © 2005 Mitropoulos et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Mitropoulos, Dionisios
Kyroudi-Voulgari, Aspasia
Theocharis, Stamatis
Serafetinides, Efraim
Moraitis, Epaminondas
Zervas, Anastasios
Kittas, Christos
Prognostic significance of metallothionein expression in renal cell carcinoma
title Prognostic significance of metallothionein expression in renal cell carcinoma
title_full Prognostic significance of metallothionein expression in renal cell carcinoma
title_fullStr Prognostic significance of metallothionein expression in renal cell carcinoma
title_full_unstemmed Prognostic significance of metallothionein expression in renal cell carcinoma
title_short Prognostic significance of metallothionein expression in renal cell carcinoma
title_sort prognostic significance of metallothionein expression in renal cell carcinoma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC545945/
https://www.ncbi.nlm.nih.gov/pubmed/15655072
http://dx.doi.org/10.1186/1477-7819-3-5
work_keys_str_mv AT mitropoulosdionisios prognosticsignificanceofmetallothioneinexpressioninrenalcellcarcinoma
AT kyroudivoulgariaspasia prognosticsignificanceofmetallothioneinexpressioninrenalcellcarcinoma
AT theocharisstamatis prognosticsignificanceofmetallothioneinexpressioninrenalcellcarcinoma
AT serafetinidesefraim prognosticsignificanceofmetallothioneinexpressioninrenalcellcarcinoma
AT moraitisepaminondas prognosticsignificanceofmetallothioneinexpressioninrenalcellcarcinoma
AT zervasanastasios prognosticsignificanceofmetallothioneinexpressioninrenalcellcarcinoma
AT kittaschristos prognosticsignificanceofmetallothioneinexpressioninrenalcellcarcinoma